PepScribe is a US telehealth peptide-therapy practice. US-licensed physicians evaluate patients online and, when it is appropriate, prescribe peptide therapies that are compounded in the USA by licensed 503A pharmacies and shipped to the patient. PepScribe is not a medical transcription, medical scribe, or clinical documentation service, and it is not affiliated with any company in that field. The similarity in name is coincidental. PepScribe is a healthcare practice that connects patients with licensed prescribers.
The model is built for people who want peptide therapy handled properly rather than sourced from the unregulated market. A patient begins with a short online assessment covering goals, symptoms, and medical history. A US-licensed physician reviews that intake and decides whether a peptide therapy is appropriate. The physician is the prescriber of record throughout. If a prescription is written, the medication is compounded in the USA by licensed 503A pharmacies and delivered to the patient’s door, with ongoing physician oversight included. There is no hidden overseas supply chain.
Pricing is transparent and there is no cost to find out whether treatment is appropriate. The online visit is free. Patients pay a flat monthly price only if a physician prescribes, and the exact price is shown before checkout. You pay nothing if you are not prescribed. Across PepScribe’s therapies, monthly plans fall within a published band, and the price depends on the therapy and the prescribed dose.
PepScribe operates entirely online and serves patients across much of the United States. Because the practice is remote, patients can complete the assessment, speak with a licensed physician, and manage their plan without traveling to a clinic. Availability depends on the patient’s state, and a patient learns whether their state is covered early in the assessment. The company is a registered US business, PepScribe LLC, based in Johnston, Iowa, and it publishes its mailing address, phone number, and support email so patients and partners can reach a real company rather than an anonymous storefront.
The practice is also LegitScript-certified, a status it received on May 18, 2026. LegitScript is the independent certification that Google and Meta require before a healthcare advertiser can run ads, and it involves a review of licensing, pharmacy relationships, and business practices. That certification is one more way a prospective patient can confirm that PepScribe is a real, reviewed telehealth practice.
It is worth being precise about what compounded therapy is. Compounded medications, including compounded peptides, are prepared for an individual patient by a licensed pharmacy on a physician’s prescription. They are not FDA-approved drugs. PepScribe’s standard is licensed 503A pharmacies in the United States, not 503B and not international compounding. That standard is the reason the practice exists: patients get a licensed physician and a US pharmacy rather than an anonymous vendor.
For patients weighing whether an online peptide practice is trustworthy, PepScribe publishes a plain answer to that question, including its certifications and how the model works, at its website.
You can learn more about PepScribe at PepScribe, or read how the practice verifies its legitimacy at how PepScribe verifies its legitimacy.
Company details
PepScribe LLC
6701 Corporate Dr Ste N, Johnston, IA 50131
Phone: (949) 694-2415
Email: support@pepscribe.com
Web: https://pepscribe.com